Govt Job for M.Pharm, B.Pharm as Quality Manager at IGIMS – Salary Rs 39,000/- pm

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi. The objective was to provide super specialty medical facilities in Bihar.

On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years. According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

Walk-In-Interview for the post of Quality Manager on contractual basis under research project “To Establish Clinical Trial Networks for hospital-based trial in Ophthalmology”.

Post :Quality Manager (01-UR)

Qualification : B.Pharma/M.Pharma preferably with management certified course
Desirable :- Experience in drug trial

Salary : 39,000/month
Age limit : 35 years
Remarks : Relaxation of age as per rule prescribed.

Candidates having requisite qualification & experience with a copy of complete BIO-DATA with their original papers and its photocopy with two passport size photographs may come for walk-in interview on date and time mentioned below.

No TA/DA is allowed for appearing in the interview. Director, IGIMS, Patna reserves the right to cancel the recruitment process at any stage without assigning any reason.

A Walk-in interview of eligible Indian Citizen for appointment of above post has been fixed on 10-07-2021 at 10:30 A.M.in the office Chamber of the HOD, RIO, IGIMS, Patna

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit